Literature DB >> 6164647

Entrapment of human leukocyte interferon in the aqueous interstices of liposomes.

P Anderson, J Vilcek, G Weissmann.   

Abstract

Human leukocyte interferon has been trapped in the aqueous interstices of multilamellar liposomes (phosphatidylcholine, dicetyl phosphate, and cholesterol [7:2:1]). Such liposomes trapped [3H]inulin (aqueous space marker) and interferon to the extent of 0.22 +/- 0.01 mg (n = 8) and 350 +/- 54 U (n = 4) per mumol of liquid, respectively, as judged by molecular sieve chromatography. Interferon trapped within liposomes was resistant to tryptic digestion under conditions which completely inactivated free interferon. Studies in which interferon was added to preformed liposomes excluded the possibility that interferon bound nonspecifically to the outer layer of the multilamellar liposomes. When interferon was added to the aqueous medium in which liposomes of various net surface charges were permitted to form, trapping of interferon varied directly with the interlamellar aqueous compartments of the liposomes. The demonstration that stable liposomes can entrap interferon suggests that these may constitute suitable vectors for the delivery of interferon to cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164647      PMCID: PMC351430          DOI: 10.1128/iai.31.3.1099-1103.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Antibodies to a cell-surface component coded by human chromosome 21 inhibit action of interferon.

Authors:  M Revel; D Bash; F H Ruddle
Journal:  Nature       Date:  1976-03-11       Impact factor: 49.962

2.  Association of mouse interferon with liposomes.

Authors:  C La Bonnardière
Journal:  FEBS Lett       Date:  1977-05-15       Impact factor: 4.124

Review 3.  The introduction of enzymes into cells by means of liposomes.

Authors:  M Finkelstein; G Weissmann
Journal:  J Lipid Res       Date:  1978-03       Impact factor: 5.922

4.  Stabilisation of mouse and human interferons by acid pH against inactivation due to shaking and guanidine hydrochloride.

Authors:  V G Edy; A Billiau; M Joniau; P De Somer
Journal:  Proc Soc Exp Biol Med       Date:  1974-05

5.  Incorporation of lysozyme into liposomes. A model for structure-linked latency.

Authors:  G Sessa; G Weissmann
Journal:  J Biol Chem       Date:  1970-07-10       Impact factor: 5.157

6.  Introduction of ribonucleic acids into cells by means of liposomes.

Authors:  G J Dimitraidis
Journal:  Nucleic Acids Res       Date:  1978-04       Impact factor: 16.971

7.  Targeting of drugs.

Authors:  G Gregoriadis
Journal:  Nature       Date:  1977-02-03       Impact factor: 49.962

8.  Evidence for translation of rabbit globin mRNA after liposome-mediated insertion into a human cell line.

Authors:  M J Ostro; D Giacomoni; D Lavelle; W Paxton; S Dray
Journal:  Nature       Date:  1978-08-31       Impact factor: 49.962

9.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro.

Authors:  C Kirby; J Clarke; G Gregoriadis
Journal:  Biochem J       Date:  1980-02-15       Impact factor: 3.857

10.  A general method for the introduction of enzymes, by means of immunoglobulin-coated liposomes, into lysosomes of deficient cells.

Authors:  G Weissmann; D Bloomgarden; R Kaplan; C Cohen; S Hoffstein; T Collins; A Gotlieb; D Nagle
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

View more
  5 in total

1.  Modification of intestinal absorption of drugs by lipoidal adjuvants.

Authors:  S Muranishi
Journal:  Pharm Res       Date:  1985-05       Impact factor: 4.200

2.  Enhanced binding of phosphatidylserine-containing lipid vesicle targets to RAW264 macrophages.

Authors:  D Rimle; W Dereski; H R Petty
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

Review 3.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Altered pharmacological properties of liposome-associated human interferon-alpha.

Authors:  D A Eppstein; W E Stewart
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

Review 5.  The potential use of liposome-mediated antiviral therapy.

Authors:  W C Koff; I J Fidler
Journal:  Antiviral Res       Date:  1985-06       Impact factor: 5.970

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.